KRAS and cancer: Using gene ontology (GO) enrichment analysis, we identified that angiogenesis, cell cycle progression, epithelial-mesenchymal transition (EMT), KRAS, and c-Myc signaling pathways were significantly downregulated in the USP22−/− cancer cells (Fig. 2b).